Transcription of Annex 9 - WHO
{{id}} {{{paragraph}}}
439 World Health OrganizationWHO Technical Report Series, No. 937, 2006 Annex 9 Additional guidance for organizations performing in vivo bioequivalence studiesIntroduction1. Scope2. Glossary 3. Organization and management 4. Computer systems Hardware Software Data management 5. Archive facilities 6. Premises 7. Clinical phase 8. Clinical laboratory 9. Personnel 10. Quality assurance 11. Ethics Independent ethics committee Informed consent 12. Monitoring 13. Investigators 14. Receiving, storage and handling of investigational drug products15. Case-report forms 16.
444 pharmaceutical product Any substance or combination of substances which has a therapeutic, pro-phylactic or diagnostic use, or is intended to …
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
ANGER MANAGEMENT: DIAGNOSTIC, ANGER MANAGEMENT: DIAGNOSTIC DIFFERENCES AND TREATMENT, Diagnostic, Treatment Approaches for Borderline Personality, Treatment Approaches for Borderline Personality Disorder, High Achieving, High Achieving Women, And therapeutic, Clinical interviewing, Low Back Disorders, BNP in the Diagnosis and, BNP in the Diagnosis and Treatment, Carpal Tunnel